PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING THE ASSOCIATION BETWEEN METABOLIC SYNDROME AND BENIGN PROSTATIC HYPERPLASIA

Authors

  • Rustamov U.M. Andijan State Medical Institute, 170100, Uzbekistan, Andijan, Atabekova st.1
  • Azimova S.B. Tashkent State Medical University, 100109 Tashkent, Uzbekistan, 2 Farobiy Street,

Keywords:

benign prostatic hyperplasia; metabolic syndrome; pathophysiology; obesity; insulin resistance; dyslipidemia; inflammation; prostate volume; prostate-specific antigen.

Abstract

Background: Benign prostatic hyperplasia (BPH) is one of the most prevalent urological disorders among aging men and represents a major cause of lower urinary tract symptoms and reduced quality of life. In recent years, metabolic syndrome (MetS) has been increasingly recognized as an important systemic factor contributing to the development and progression of BPH. Metabolic abnormalities, including central obesity, insulin resistance, dyslipidemia, hypertension, and impaired glucose metabolism, promote chronic inflammation, oxidative stress, endothelial dysfunction, and hormonal imbalance, thereby creating a favorable environment for prostatic enlargement. However, the pathophysiological mechanisms linking metabolic syndrome with benign prostatic hyperplasia remain incompletely understood.

References

EAU Guidelines Office. EAU Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS), including Benign Prostatic Obstruction. Arnhem, The Netherlands: European Association of Urology; 2025.

American Urological Association. Guideline: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (2024 Update). Linthicum (MD): American Urological Association; 2024.

McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline for management of benign prostatic hyperplasia. J Urol. 2024;211(2):245–258.

Ng CF. The relationship between metabolic syndrome and benign prostatic hyperplasia: Current evidence and clinical implications. Asian J Urol. 2021;8(3):239–246.

Wang Y, Bao Y, Liu J, Duan L, Cui Y. Association between metabolic syndrome and benign prostatic hyperplasia: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(14):e25308.

Gacci M, Corona G, Vignozzi L, et al. Metabolic syndrome and benign prostatic enlargement: Pathophysiological links and clinical implications. Nat Rev Urol. 2021;18(2):108–123.

Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol. 2022;19(9):534–548.

Chughtai B, Forde JC, Thomas DDM, et al. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2023;9(1):18.

Grundy SM. Metabolic syndrome update: Trends and clinical perspectives. Circulation. 2022;145(9):e722–e733.

Saklayen MG. The global epidemic of metabolic syndrome. Curr Hypertens Rep. 2021;23(2):10.

La Vignera S, Condorelli RA, Russo GI, Calogero AE. Endocrine control of benign prostatic hyperplasia and metabolic syndrome. Andrology. 2022;10(6):1068–1078.

Russo GI, Cimino S, Castelli T, et al. Insulin resistance and lower urinary tract symptoms: A systematic review. Int J Mol Sci. 2022;23(9):4876.

Yassin A, Haider A, Haider KS, et al. Obesity, metabolic syndrome and lower urinary tract symptoms in aging men. World J Mens Health. 2023;41(2):245–259.

Maggi M, Vignozzi L, Gacci M. Chronic inflammation as a link between metabolic syndrome and benign prostatic hyperplasia. Int J Mol Sci. 2023;24(5):4587.

International Diabetes Federation (IDF). The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: International Diabetes Federation; Updated 2023.

Roehrborn CG. Pathophysiology of benign prostatic hyperplasia and lower urinary tract symptoms: Recent advances. Urology. 2022;166:10–18.

Parsons JK. Lifestyle factors, metabolic syndrome and benign prostatic hyperplasia. Curr Opin Urol. 2021;31(1):15–21.

Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia in patients with metabolic syndrome. Curr Opin Urol. 2023;33(3):235–242.

Downloads

Published

2026-07-16